Steve Whittaker

Former Director of Clinical Affairs Europe at HeartWare International, Inc.

Steve Whittaker

Steve Whittaker

Former Director of Clinical Affairs Europe at HeartWare International, Inc.

Biography

Steve Whittaker is former Vice President-Clinical & Regulatory Affairs at Sequana Medical AG.

Overview
RelSci Relationships

93

Relationships
RelSci Relationships are individuals Steve Whittaker likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Former Executive Director Policy, Business Questions at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Vice President at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Treasurer at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

President at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Director at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Former Chair, Board of Directors at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Secretary, Board of Directors at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Director at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

Chair, Board of Directors at American Society of Media Photographers, Inc.

Relationship likelihood: Strong

In The News
Paths to Steve Whittaker
Potential Connections via
Relationship Science
You
Steve Whittaker
Former Director of Clinical Affairs Europe at HeartWare International, Inc.
Career History
Vice President of Clinical Affairs
Prior

Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland.

Director
Tenure Unconfirmed

American Society of Media Photographers, Inc. is an American private company located in Philadelphia, PA. The firm operates as a trade association for photographers. James Edmund Datri is the current CEO, occupying that position since 2020.

Director of Clinical Affairs Europe
Tenure Unconfirmed

HeartWare is a global medical device company dedicated to delivering safe, high-performing and transformative therapies that enable patients with heart failure to get back to life. The company’s innovative technologies are creating advances in the miniaturization of Ventricular Assist Devices (VADs) leading to less invasive surgical procedures and increasing the patient population who may be suitable for VAD therapy. Heart failure is a degenerative, terminal disease affecting more than 20 million patients worldwide and causing more than 7.25 million deaths each year. Approximately 1 million patients suffer from Class IV heart failure, the most severe stage of the disease. Heart transplantation is a proven treatment option for class IV heart failure patients, but a limited number of donor hearts become available each year. Ventricular assist devices can provide circulatory support until a donor heart becomes available (called bridge-to-transplant therapy), or provide long-term support as an alternative to transplantation (called destination therapy in many countries). HeartWare’s breakthrough innovations begin with the company’s miniaturized ventricular assist device, called the HVAD® Pump, designed to be implanted next to the heart in the pericardial space avoiding the more invasive surgical procedures required with older LVAD technologies. HeartWare® Ventricular Assist System Featuring the HVAD Pump is Available Around the World The HeartWare Ventricular Assist System obtained U.S. market approval in November 2012 from the U.S. Food and Drug Administration (FDA) as a bridge-to-transplant therapy for patients with advanced stage heart failure. The HeartWare® System has been commercially available in other global markets including Europe and Australia, since 2009. To date, more than 2,500 patients worldwide have been treated with the HeartWare® Ventricular Assist System. HeartWare is listed on the NASDAQ Stock Market under the symbol HTWR, and the Australian Securities Exchange under the symbol HIN. HeartWare’s corporate headquarters are in Framingham, Massachusetts. The company’s operating and manufacturing activities are based in Miami Lakes, Florida, and Sydney, NSW, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steve Whittaker. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steve Whittaker's profile does not indicate a business or promotional relationship of any kind between RelSci and Steve Whittaker.